Zydus Life: Analysts caution EPS dilution post Amplitude acquisition; check latest targets
Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...
Nasdaq7d
What Is the Treasury Stock Method and How Is It Used?
The Treasury Stock Method provides valuable insights for investors by illustrating the potential dilution effect on a company’s EPS. This method is particularly useful for assessing the ...
CNBCTV183d
Zydus Life shares get price target cuts, caution from analysts
Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...
Brokerages caution against subpar synergies in Zydus Life's acquisition of Amplitude Surgical
Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...
Park-Ohio Holdings' (NASDAQ:PKOH) Shareholders May Want To Dig Deeper Than Statutory Profit
Park-Ohio Holdings Corp.'s ( NASDAQ:PKOH ) robust recent earnings didn't do much to move the stock. We believe ...
Seeking Alpha20d
Zscaler: Out With The New, In With The Old (Revisited)
1,808 ($207/ $0.1145), which is about 13% higher than without the inclusion of dilutive shares. To put this huge P/E ratio of 1,592 into perspective, EPS would need to grow by 115% CAGR to get a P ...
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio
Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.